FindTrial
Sign In

Randomised controlled clinical study to Compare efficacy of Murivenna Topical Patch Versus Diclofenac Topical Patch in pain management of Ankle Sprain

Evaluation of Comparative Efficacy of Murivenna Topical Patch Versus Diclofenac Topical Patch in Pain Management of Ankle Sprain- A RCT - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080916
Enrollment
160
Registered
2025-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S934- Sprain of ankle

Interventions

None listed

Sponsors

Shijo YJ
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to give written informed consent Patients of age between 21-50 Fulfilling the criteria of clinical Diagnosis of Mild to Moderate Ankle sprain Obvious signs of Ankle sprain with pain, swelling and tenderness. Ankle injury not more than 48 hours

Exclusion criteria

Exclusion criteria: Patients suffering from Connective tissue disorders Ankle sprain Grade iii DVT History of recurrent ankle sprain. Pregnancy

Design outcomes

Primary

MeasureTime frame
Reducing obvious signs and symptoms of Ankle sprain 1.pain 2.swelling 3.tenderness. 4.Improvement in ankle movement.Timepoint: Murivenna Topical patch for 7 days Follow up after 14 and 28 days—

Secondary

MeasureTime frame
Expecting improvement clinically Reduced symptoms of ankle joint pain and swelling Improvement in quality of lifeTimepoint: Expecting improvement clinically within in 7 days—

Countries

India

Contacts

Public ContactDr Sheetal Asutkar

Mahatma Gandhi Ayurved College, Hospital And Research Centre

sheetal.gujjanwar@dmiher.edu.in9766811974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026